This category of defects includes defects of the synthesis of IGF-1 and IGF-2 due to gene mutation, abnormalities of the IGF-1 receptor, bio inactive IGF-1, and defects of IGFBP-3 or ALS. This evidence concerns the gene IGF1 and amyotrophic lateral sclerosis.